Summary of Budget Mechanism Total

Fiscal Year 2020 Superfund Budget

(Dollars in Thousands)

Footnote: 1, 2, 3

• Superfund Congressional Justification (full document) (600KB)

MECHANISM	FY 2018 Final4		FY 2019 Enacted5		FY 2020 President's Budget6		FY 2020 +/- FY 2019
	No.	Amount	No.	Amount	No.	Amount	No.	Amount
Research Projects:
Noncompeting	25,858	$13,776,726	27,492	$14,677,360	28,760	$14,536,572	1,268	-$140,788
Administrative Supplements3	(2,743)	483,035	(2,695)	506,430	(1,858)	361,166	(-837)	-145,264
Competing	11,461	$5,943,802	11,675	$6,311,423	7,894	$3,725,852	-3,781	-$2,585,571
Subtotal, RPGs	37,319	$20,203,562	39,167	$21,495,213	36,654	$18,623,590	-2,513	$2,871,623
SBIR/STTR	2,035	1,001,946	2,222	1,084,179	1,911	921,133	-311	-163,046
Research Project Grants	39,354	$21,205,508	41,389	$22,579,392	38,565	$19,544,723	-2,824	-$3,034,669
Research Centers:
Specialized/Comprehensive	1,003	$1,813,976	1,079	$1,908,419	924	$1,547,608	-155	-$360,811
Clinical Research	68	417,709	66	421,640	64	362,000	-2	-59,640
Biotechnology	91	159,963	91	160,916	80	138,518	-11	-22,398
Comparative Medicine	67	129,881	79	133,759	67	115,233	-12	-18,526
Research Centers in Minority Institutions	21	61,478	20	63,407	20	54,594	0	-8,814
Research Centers	1,250	$2,583,007	1,335	$2,688,141	1,155	$2,217,953	-180	-$470,188
Other Research:
Research Careers	4,040	$747,017	4,161	$780,492	3,792	$708,160	-369	-$72,332
Cancer Education	76	21,182	85	24,857	81	23,614	-4	-1,243
Cooperative Clinical Research	229	409,660	278	497,025	243	411,324	-35	-85,701
Biomedical Research Support	118	85,524	112	73,696	95	62,825	-17	-10,872
Minority Biomedical Research Support	283	101,245	294	104,359	228	81,111	-66	-23,248
Other	2,064	1,081,442	2,066	1,009,259	1,805	922,686	-261	-86,572
Other Research	6,810	$2,446,070	6,996	$2,489,688	6,244	$2,209,720	-752	-$279,968
Total Research Grants	47,414	$26,234,584	49,720	$27,757,221	45,964	$23,972,395	-3,756	-$3,784,825
Ruth L. Kirschstein Training Awards	FTTPs		FTTPs		FTTPs		FTTPs
Individual Awards	3,500	$161,753	3,697	$173,134	3,335	$157,779	-362	-$15,355
Institutional Awards	12,697	694,093	12,969	715,821	11,657	644,094	-1,312	-71,727
Total Research Training	16,197	$855,845	16,666	$888,955	14,992	$801,873	-1,674	-$87,082
Research & Develop. Contracts	2,212	$3,072,532	2,177	$3,132,619	1,862	$2,795,430	-315	-$337,189
SBIR/STTR (non-add)3	(85)	(60,608)	(98)	(74,336)	(79)	(64,122)	(-19)	(-10,214)
Intramural Research		$3,996,276		$4,129,550		$3,633,805		-$495,745
Res. Management & Support		1,816,210		1,898,356		1,739,376		-158,979
Res. Management & Support (SBIR Admin) (non-add)3		(0)		(5,172)		(3,559)		(-1,613)
Office of the Director - Appropriation3,7		(1,914,345)		(2,112,675)		(1,926,144)		(-186,531)
Office of the Director - Other		1,024,420		1,204,300		1,144,168		-60,132
ORIP (non-add)3,7		(289,209)		(289,209)		(249,009)		(-40,200)
Common Fund (non-add)3,7		(600,716)		(619,166)		(532,967)		(-86,199)
Buildings and Facilities8		146,863		218,000		214,000		-4,000
Appropriation3		(128,863)		(200,000)		(200,000)		0
Type 1 Diabetes9		-150,000		-150,000		-150,000		0
Program Evaluation Financing9		-922,871		-1,146,821		-741,000		405,821
Subtotal, Labor/HHS Budget Authority		$36,073,860		$37,932,179		$33,410,048		-$4,522,131
Interior Appropriation for Superfund Research10		77,349		77,349		66,581		-10,768
Total, NIH Discretionary Budget Authority		$36,151,209		$38,009,528		$33,476,629		-$4,532,899
Type 1 Diabetes		150,000		150,000		150,000		0
Total, NIH Budget Authority		$36,301,209		$38,159,528		$33,626,629		-$4,532,899
Program Evaluation Financing		922,871		1,146,821		741,000		-405,821
Total, Program Level		$37,224,080		$39,306,349		$34,367,629		-$4,938,720

¹ All Subtotal and Total numbers may not add due to rounding.
² Includes 21st Century Cures Act funding and excludes Ebola-related and supplemental financing.
³ All numbers in italics and brackets are non-add.
⁴ Includes $63.3 million of 21st Century Cures, $428.9 million of Opioids, and $123.7 million of Type 1 Diabetes funding not obligated in FY 2018, and carried over into FY 2019. Numbers of grants and dollars for carryover are distributed by mechanism.
⁵ Reflects transfer of $5.0 million to the HHS OIG.
⁶ Includes funding for National Institute for Research on Safety and Quality (formerly the Agency for Healthcare Research and Quality) distributed by mechanism.
⁷ Number of grants and dollars for the Common Fund and ORIP components of OD are distributed by mechanism and are noted here as non-adds. Office of the Director - Appropriation is the non-add total of these amounts and the funds accounted for under OD - Other.
⁸ Includes B&F appropriation and monies allocated ($18.0 million in FY 2018, $18.0 million in FY 2019, and $14.0 million in FY 2020) pursuant to appropriations acts provisions that funding may be used for facilities repairs and improvements at the NCI Federally Funded Research and Development Center in Frederick, Maryland.
⁹ Amounts for AHRQ and PCORTF are shown in FY 2018 and FY 2019 to produce comparable tools for NIH budget authority and program level. Amounts are not distributed by mechanism.
¹⁰ Number of grants and dollars for mandatory Type 1 Diabetes (TID) and NIGMS Program Evaluation financing are distributed by mechanism above; therefore, TID and Program Evaluation financing amounts are deducted to provide subtotals for Labor/HHS Budget Authority.
¹¹ This activity was under a Continuing Resolution at the time the budget estimates were prepared.